Greggs to open 150 new stores this year
The bakery chain said it was aiming at opening the new outlets after opening 186 new shops in 2022.As of December 31, it operated 2,328 shops across the UK.Roisin Currie, chief executive officer, said the company had an "exciting, ambitious plan" for the years ahead.
"By continuing to nurture what makes Greggs special, I believe we are extremely well-placed to realise the opportunity to become a significantly larger, multi-channel business," she said.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Greggs plans to open 150 new stores despite elevated pay and energy costsThe company says it expects to see an impact from elevated levels of inflation throughout 2023 but it says its value offer is proving attractive as the cost of living crisis continues.
Read more »
Jeremy Clarkson farm shop customer pays 150% more on fry-up than at supermarketWhile the food came with a hefty price tag, Lifestyle Writer Ariane Sohrabi-Shiraz was impressed by one item in particular.
Read more »
Cities: Skylines 2 will have hailstorms, rat infestations, and 150 map tiles in a single cityA mod for Cities: Skylines let you build on 81 map tiles instead of just 9, but Cities: Skylines 2 will let you unlock 150 map tiles in a single city, according to its Xbox achievement list. (Also, there are rats.)
Read more »
Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survivalLung cancer is a product of inflammation and a dysfunctional immune system, and depression has similar dysregulation. Depression disproportionately affects lung cancer patients, having the highest rates of all cancers. Systemic inflammation and depression are both predictive of non-small cell lung cancer (NSCLC) survival, but the existence and extent of any co-occurrence is unknown. Studied is the association between systemic inflammation ratio (SIR) biomarker levels and patients’ depressive symptoms, with the hypothesis that depression severity would be significantly associated with prognostically poor inflammation. Newly diagnosed stage-IV non-small cell lung cancer (NSCLC; N=186) patients were enrolled (ClinicalTrials.gov Identifier: NCT03199651) and blood draws and depression self-reports (Patient Health Questionnaire-9) were obtained. For SIRs, cell counts of neutrophils (N), lymphocytes (L), and platelets (P) were abstracted for ratio (R) calculations for NLR, PLR, and the Advanced Lung cancer Inflammation Index (ALI). Patients were followed and biomarkers were tested as predictors of 2-year overall survival (OS) to confirm their relevance. Next, multivariate linear regressions tested associations of depression with NLR, PLR, and ALI. Overall 2-year mortality was 61% (113/186). Cox model analyses confirmed higher NLR [hazard ratio (HR)=1.91; p=0.001] and PLR (HR=2.08; p|0.001), along with lower ALI (HR=0.53; p=0.005), to be predictive of worse OS. Adjusting for covariates, depression was reliably associated with biomarker levels (p ≤ 0.02). Patients with moderate/severe depressive symptoms were 2 to 3 times more likely to have prognostically poor biomarker levels. Novel data show patients’ depressive symptoms were reliably associated with lung-relevant systemic inflammation biomarkers, all assessed at diagnosis/pretreatment. The same SIRs were found prognostic for patients’ 2-year OS. Intensive study of depression, combined with measures of cell biology and in
Read more »
Much-loved clothing store closes 'with a heavy heart' after 18 yearsA much-loved clothing store has closed 'with a heavy heart' after 18 years.
Read more »